AU1580995A - Use of diesters of muramyl peptides in oral form as immunostimulating agents - Google Patents

Use of diesters of muramyl peptides in oral form as immunostimulating agents

Info

Publication number
AU1580995A
AU1580995A AU15809/95A AU1580995A AU1580995A AU 1580995 A AU1580995 A AU 1580995A AU 15809/95 A AU15809/95 A AU 15809/95A AU 1580995 A AU1580995 A AU 1580995A AU 1580995 A AU1580995 A AU 1580995A
Authority
AU
Australia
Prior art keywords
diesters
oral form
muramyl peptides
immunostimulating agents
immunostimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15809/95A
Other languages
English (en)
Inventor
Francoise Audibert
Louis Chedid
Pierre Lefrancier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vacsyn SA
Original Assignee
Vacsyn SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vacsyn SA filed Critical Vacsyn SA
Publication of AU1580995A publication Critical patent/AU1580995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU15809/95A 1994-01-25 1995-01-24 Use of diesters of muramyl peptides in oral form as immunostimulating agents Abandoned AU1580995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9400786 1994-01-25
FR9400786A FR2715305B1 (fr) 1994-01-25 1994-01-25 Diesters de muramyl peptides dans une forme orale.
PCT/FR1995/000077 WO1995019777A2 (fr) 1994-01-25 1995-01-24 Utilisation de diesters de muramyl peptides, dans une forme orale, comme immunostimulants

Publications (1)

Publication Number Publication Date
AU1580995A true AU1580995A (en) 1995-08-08

Family

ID=9459376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15809/95A Abandoned AU1580995A (en) 1994-01-25 1995-01-24 Use of diesters of muramyl peptides in oral form as immunostimulating agents

Country Status (6)

Country Link
EP (1) EP0741573A1 (fr)
JP (1) JPH09509409A (fr)
AU (1) AU1580995A (fr)
CA (1) CA2181899A1 (fr)
FR (1) FR2715305B1 (fr)
WO (1) WO1995019777A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2730935A1 (fr) * 1994-12-21 1996-08-30 Vacsyn Sa Vaccin presentant une immunogenicite accrue
FR2730936B1 (fr) * 1994-12-21 1997-10-31 Vacsyn Sa Vaccin presentant une immunogenicite accrue
FR2732604B1 (fr) * 1995-04-07 1997-06-06 Vacsyn Sa Derives et conjugues du mdp presentant une activite stimulatrice de la fonction hematopoietique et compositions les contenant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153684A (en) * 1976-03-10 1979-05-08 Agence Nationale De Valorisation De La Recherche (Anvar) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
EP0026746B1 (fr) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Compositions combinées utilisables dans un procédé pour augmenter l'activité des antibiotiques, compositions antibiotiques ayant une efficacité accrue et procédé pour leur préparation
FR2672495B1 (fr) * 1991-02-08 1995-10-20 Vacsyn France Sa Compositions immunomodulatrices, a base de produits comportant au moins un groupe phosphate ou sulfate, et un gel d'un compose d'aluminium.

Also Published As

Publication number Publication date
WO1995019777A2 (fr) 1995-07-27
FR2715305B1 (fr) 1996-03-15
FR2715305A1 (fr) 1995-07-28
WO1995019777A3 (fr) 1996-03-07
CA2181899A1 (fr) 1995-07-27
EP0741573A1 (fr) 1996-11-13
JPH09509409A (ja) 1997-09-22

Similar Documents

Publication Publication Date Title
GB2313783B (en) Oral 2-Methyl-Thieno-Benzodiazepine formulation
IL118004A0 (en) Vaccine compositions
EP0702940A3 (fr) Structure de restauration dentaire
IL117249A0 (en) Vaccine compositions
AU7242994A (en) Model for testing immunogenicity of peptides
HUP9800696A3 (en) Compositions and methods for use in a aquaculture
AU2372095A (en) Oral compositions
NZ240369A (en) Muramyl dipeptide derivatives and vaccine compositions
GB9401787D0 (en) Vaccine compositions
AU2893595A (en) Use of muramyl peptide compounds
GB9516293D0 (en) Novel peptides and their use as vaccines
AU2427895A (en) Oral compositions
AU1580995A (en) Use of diesters of muramyl peptides in oral form as immunostimulating agents
AU3527495A (en) Use of muramyl peptide compounds
IL116134A0 (en) Iminooxybenzylcrotonate esters their preparation and their use
IL123421A0 (en) Phenylacetic acids their preparation and compositions comprising them
GB9618673D0 (en) The use of muramyl peptides
AU2476892A (en) Improvements in dental crowns
AU5874496A (en) The use of c16-c18alkylpolyglycosides as d efoamers in cleaning compositions
AU3423397A (en) Therapeutic methods and compositions for use therein
AU1824195A (en) Oral synthetic peptide preparation
GB2292886B (en) Oral hygiene formulation
GB9601739D0 (en) Vaccine Compositions
GB9425980D0 (en) Vaccine compositions
GB9416097D0 (en) Vaccine compositions